Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRV120027 in Stable Heart Failure
NCT01187836Phase 2Completed
- Sponsor
- Trevena, Inc.
- Start
- Dec 2010
- Primary completion
- Mar 2012
- Modality
- Peptides, Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) comparing TRV120027 with Placebo (2 arms). Primary endpoints: Pulmonary Capillary Wedge Pressure and Safety and Tolerability at Day 30. Started Dec 2010; status: completed.
02
Drugs
TRV120027
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01187836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01187836.